Description: Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, stenosis, carotid artery, and vascular access device. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
Home Page: www.zyloxtb.com
Building 1
Hangzhou,
China
Phone:
86 571 8861 0082
Officers
| Name | Title |
|---|---|
| Dr. Zhong Zhao | Founder, Chairman & CEO |
| Mr. Yang Xie | Sr. VP of Sales & Marketing and Exec. Director |
| Dr. Zheng Li | Sr. VP, GM of Neurovascular Bus. & Exec. Director |
| Mr. Quanwei Yuan | CFO & Joint Company Sec. |
| Dr. Ning Pan | Sr. VP of R&D for peripheral vascular business |
| Ms. Sau In Kwan | Joint Company Sec. |
Exchange: HK
Country: HK : Hong Kong
Currency: Hong Kong Dollar (HK$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.1308 |
| Price-to-Sales TTM: | 16.6476 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 594 |